Expert Review of Neurotherapeutics

Papers
(The TQCC of Expert Review of Neurotherapeutics is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system52
Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease51
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives46
Therapeutic advances in Dravet syndrome: a targeted literature review44
Manganese-induced neurodegenerative diseases and possible therapeutic approaches36
Update on diagnosis in disorders of consciousness34
Diagnosing and managing post-stroke aphasia33
Clinical diagnosis and management of small fiber neuropathy: an update on best practice33
The emerging role of psilocybin and MDMA in the treatment of mental illness29
Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice29
Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy28
A systematic review of morbidities suggestive of the multiple sclerosis prodrome28
Sex differences in schizophrenia relevant to clinical care27
The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders27
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies27
Focal cortical dysplasia: an update on diagnosis and treatment26
Nutrition-based interventions for mood disorders25
Role of environmental factors in multiple sclerosis24
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults23
What is the potential of neurostimulation in the treatment of motor symptoms in schizophrenia?23
Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis22
Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review21
Emerging therapies in Friedreich’s Ataxia21
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome21
Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs20
Clinical development of valbenazine for tics associated with Tourette syndrome20
Gene therapy for Parkinson’s disease: contemporary practice and emerging concepts20
Cannabis and multiple sclerosis20
Pain in cervical dystonia: mechanisms, assessment and treatment20
Robot Assisted Ankle Neuro-Rehabilitation: State of the art and Future Challenges19
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease19
An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management19
Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone19
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?18
Motor imagery and gait control in Parkinson’s disease: techniques and new perspectives in neurorehabilitation18
mHealth for pediatric chronic pain: state of the art and future directions18
Psychotherapy in recurrent depression: efficacy, pitfalls, and recommendations17
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia17
Sensory stimulation programs in dementia: a systematic review of methods and effectiveness17
Medication overuse headache: an overview of clinical aspects, mechanisms, and treatments17
Acute ischemic stroke management: concepts and controversies.A narrative review17
The effect of physical activity with and without cognitive demand on the improvement of executive functions and behavioral symptoms in children with ADHD17
Efficacy and safety of greater occipital nerve block for the treatment of cluster headache: a systematic review and meta-analysis17
MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis16
Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms16
Adaptive, personalized closed-loop therapy for Parkinson’s disease: biochemical, neurophysiological, and wearable sensing systems16
Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies16
Combination therapy in migraine: asset or issue?16
Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis16
Current perspectives on galvanic vestibular stimulation in the treatment of Parkinson’s disease15
Treatment of infantile spasms: why do we know so little?15
Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice15
Speech and language therapy in primary progressive aphasia: a critical review of current practice15
Recent advancements in tension-type headache: a narrative review15
The efficacy of executive function interventions in children with autism spectrum disorder: a systematic review and meta-analysis14
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring14
What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group14
Post-traumatic hydrocephalus: the Cinderella of Neurotrauma14
Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis14
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis14
Considering patient age when treating multiple sclerosis across the adult lifespan13
The role of a potential biomarker in patients with migraine: review and new insights13
Status epilepticus in pregnancy: a literature review and a protocol proposal13
Reading mind from the eyes in individuals with attention deficit-hyperactivity disorder (ADHD): A meta-analysis13
Real world considerations for newly approved CGRP receptor antagonists in migraine care13
An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis13
Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis13
A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders13
Sydenham’s chorea: from pathophysiology to therapeutics13
The evidence for multidisciplinary care in Parkinson’s disease13
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics13
Is it accurate to classify ALS as a neuromuscular disorder?12
Evaluating and managing severe headache in the emergency department12
Current perspectives on exercise training in the management of multiple sclerosis12
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders12
Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence12
Outcomes measures in idiopathic intracranial hypertension12
Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease11
Current perspectives on the benefits, risks, and limitations of noninvasive brain stimulation (NIBS) for post-stroke dysphagia11
Current and emerging treatment modalities for spinocerebellar ataxias11
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry11
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion11
Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders11
Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approaches11
Updated review on the link between cortical spreading depression and headache disorders11
Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting11
The therapeutic effect of habit reversal training for Tourette syndrome: a meta-analysis of randomized control trials11
Can mindfulness-based interventions benefit people with dementia? Drawing on the evidence from a systematic review in populations with cognitive impairments11
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy11
The second phase of brain trauma can be controlled by nutraceuticals that suppress DAMP-mediated microglial activation11
A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome10
What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?10
Neurotechnologies as tools for cognitive rehabilitation in stroke patients10
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis10
Considering hearing loss as a modifiable risk factor for dementia10
Developments in treating the nonmotor symptoms of stroke10
Current perspectives on sex differences in tension-type headache10
Incisionless MR-guided focused ultrasound: technical considerations and current therapeutic approaches in psychiatric disorders9
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment9
Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper9
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?9
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis9
Vitamin D in the development and progression of alzheimer’s disease: implications for clinical management9
A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures9
Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review9
Nutraceutical induction and mimicry of heme oxygenase activity as a strategy for controlling excitotoxicity in brain trauma and ischemic stroke: focus on oxidative stress9
A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters9
0.11627507209778